1352914-52-3 Usage
Uses
Used in Pharmaceutical Development:
(?)-CR-1-31-B is used as a potential drug candidate for the development of therapeutic interventions in various diseases, including cancer, inflammation, and neurodegenerative disorders. Its ability to inhibit specific enzymes and receptors makes it a promising candidate for future pharmaceutical development.
Used in Medicinal Chemistry Research:
(?)-CR-1-31-B is used as a subject of study in medicinal chemistry research to further understand its biological activities and pharmacological properties. This research aims to explore its potential as a therapeutic agent and to identify possible applications in the treatment of various diseases.
Further research is needed to fully understand the biological activities and pharmacological properties of (?)-CR-1-31-B, but its potential as a novel organic compound with applications in medicinal chemistry and drug development is evident.
Check Digit Verification of cas no
The CAS Registry Mumber 1352914-52-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,9,1 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1352914-52:
(9*1)+(8*3)+(7*5)+(6*2)+(5*9)+(4*1)+(3*4)+(2*5)+(1*2)=153
153 % 10 = 3
So 1352914-52-3 is a valid CAS Registry Number.
1352914-52-3Relevant academic research and scientific papers
Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: Synthetic and biological studies
Rodrigo, Christina M.,Cencic, Regina,Roche, Stéphane P.,Pelletier, Jerry,Porco, John A.
, p. 558 - 562 (2012/02/16)
The rocaglates/rocaglamides are a class of natural products known to display potent anticancer activity. One such derivative, silvestrol, has shown activity comparable to taxol in certain settings. Here, we report the synthesis of various rocaglamide anal
